참고문헌
- Barber RC. The Genetics of Alzheimer's Disease. Scientifica. 2012. 2012: 14.
- Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011. 10: 819-828. https://doi.org/10.1016/S1474-4422(11)70072-2
- Bossuyt P. Clinical validity: defining biomarker performance. Scand J Clin Lab Invest Suppl. 2010. 242: 46-52.
- Brion J. Neurofibrillary tangles and Alzheimer's disease. Eur Neurol. 1998. 40: 130-140. https://doi.org/10.1159/000007969
- Cheng L, Quek C, Sun X, Bellingham SA, Hill AF. Deepsequencing of microRNA associated with Alzheimer's disease in biological fluids: From biomarker discovery to diagnostic practice. Fron Genet. 2013. 4: 150.
- Cogswell JP, Ward J, Taylor IA, Waters M, Shi Y, Cannon B, Kelnar K, Kemppainen J, Brown D, Chen C, Prinjha RK, Richardson JC, Saunders AM, Roses AD, Richards CA. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis. 2008. 14: 27-41. https://doi.org/10.3233/JAD-2008-14103
- Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: Novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res. 2012. 110: 483-495. https://doi.org/10.1161/CIRCRESAHA.111.247452
- Crowther RA. Straight and paired helical filaments in Alzheimer disease have a common structural unit. Proc Natl Acad Sci USA. 1991. 88: 2288-2292. https://doi.org/10.1073/pnas.88.6.2288
- Diehl P, Fricke A, Sander L, Stamm J, Bassler N, Htun N, Ziemann M, Helbing T, El-Osta A, Jowett JBM, Peter K. Microparticles:major transport vehicles for distinct microRNAs in circulation. Cardiovasc Res. 2012. 93: 633-644. https://doi.org/10.1093/cvr/cvs007
- Dong S, Duan Y, Hu Y, Zhao Z. Advances in the pathogenesis of Alzheimer's disease: a re-evaluation of amyloid cascade hypothesis. Transl Neurodegener. 2012. 1: 18. https://doi.org/10.1186/2047-9158-1-18
- Du L, Pertsemlidis A. Cancer and neurodegenerative disorders:pathogenic convergence through microRNA regulation. J Mol Cell Biol. 2011. 3: 176-180. https://doi.org/10.1093/jmcb/mjq058
- Fagan AM, Perrin RJ. Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease. Biomark Med. 2012. 6: 455-476. https://doi.org/10.2217/bmm.12.42
- Gotz J, Schild A, Hoerndli F, Pennanen L. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models. Int J Dev Neurosci. 2004. 22: 453-465. https://doi.org/10.1016/j.ijdevneu.2004.07.013
- Gandhi R, Healy B, Gholipour T, Egorova S, Musallam A, Hussain MS, Nejad P, Patel B, Hei H, Khoury S, Quintana F, Kivisakk P, Chitnis T, Weiner HL. Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosis. Ann Neurol. 2013. 73: 729-740. https://doi.org/10.1002/ana.23880
- Guay C, Regazzi R. Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol. 2013. 9: 513-521. https://doi.org/10.1038/nrendo.2013.86
- Guerreiro RJ, Gustafson DR, Hardy J. The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE. Neurobiol Aging. 2012. 33: 437-456. https://doi.org/10.1016/j.neurobiolaging.2010.03.025
- Hodges JR. Alzheimer's centennial legacy: origins, landmarks and the current status of knowledge concerning cognitive aspects. Brain. 2006. 129: 2811-2822. https://doi.org/10.1093/brain/awl275
- Hong-Qi Y, Zhi-Kun S, Sheng-Di C. Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Abeta and tau. Transl Neurodegener. 2012. 1: 21. https://doi.org/10.1186/2047-9158-1-21
- Humpel C. Identifying and validating biomarkers for Alzheimer's disease. Trends Biotechnol. 2011. 29: 26-32. https://doi.org/10.1016/j.tibtech.2010.09.007
- Hutton M. The presenilins and Alzheimer's disease. Hum Mol Genet. 1997. 6: 1639-1646. https://doi.org/10.1093/hmg/6.10.1639
- Jackson-Siegal J. Our current understanding of the pathophysiology of Alzheimer's disease advanced studies in pharmacy. Adv Stud Pharm. 2005. 2: 126-135.
- Koutsilieri E, Rethwilm A, Scheller C. The therapeutic potential of siRNA in gene therapy of neurodegenerative disorders. J Neural Transm Suppl. 2007. 72: 43-49. https://doi.org/10.1007/978-3-211-73574-9_7
- Kumar P, Dezso Z, MacKenzie C, Oestreicher J, Agoulnik S, Byrne M, Bernier F, Yanagimachi M, Aoshima K, Oda Y. Circulating miRNA biomarkers for Alzheimer's disease. PLoS One. 2013. 8: e69807. https://doi.org/10.1371/journal.pone.0069807
- Lukiw W. NF-kappaB-regulated, proinflammatory miRNAs in Alzheimer's disease. Alzheimers Res Ther. 2012. 4: 47. https://doi.org/10.1186/alzrt150
- Mayeux R. Biomarkers: potential uses and limitations. Neurotherapeutics. 2004. 1: 182-188. https://doi.org/10.1602/neurorx.1.2.182
- Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci. 2008. 105: 10513-10518. https://doi.org/10.1073/pnas.0804549105
- Mokhtar SH, Bakhuraysah MM, Cram DS, Petratos S. The beta-amyloid protein of Alzheimer's disease: Communication breakdown by modifying the neuronal cytoskeleton. Intern J Alzheimers Dis. 2013. 2013: 15.
- Mrak RE, Griffin WST. Potential inflammatory biomarkers in Alzheimer's disease. J Alzheimers Dis. 2005. 8: 369-375.
- Orlacchio A, Bernardi G, Orlacchio A, Martino S. RNA interference as a tool for Alzheimer's disease therapy. Mini Rev Med Chem. 2007. 7: 1166-1176. https://doi.org/10.2174/138955707782331678
- Pasinetti GM. Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia. J Neurosci Res. 2001. 65: 471-476. https://doi.org/10.1002/jnr.1176
- Ray M, Ruan J, Zhang W. Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases. Genome Biol. 2008. 9: R148. https://doi.org/10.1186/gb-2008-9-10-r148
- Reger B. Alzheimer's Disease: A brief history and avenues for current research. J Young Invest. 2002. 6.
- Reitz C. Alzheimer's disease and the amyloid cascade hypothesis:A critical review. Intern J Alzheimers Dis. 2012. 2012: 11.
- Ricciarelli R, d'Abramo C, Massone S, Marinari UM, Pronzato MA, Tabaton M. Microarray analysis in Alzheimer's disease and normal aging. IUBMB Life. 2004. 56: 349-354. https://doi.org/10.1080/15216540412331286002
- Rosen C, Hansson O, Blennow K, Zetterberg H. Fluid biomarkers in Alzheimer's disease - current concepts. Mol Neurodegener. 2013. 8: 20. https://doi.org/10.1186/1750-1326-8-20
- Salawu F, Umar J, Olokoba A. Alzheimer's disease: A review of recent developments. Ann Afr Med. 2011. 10: 73-79. https://doi.org/10.4103/1596-3519.82057
- Shun C, Xuemei G, Yinghui C, Nan L, Zhenguo L, Weien Y. Advances with RNA interference in Alzheimer's disease research. Drug Des Devel Ther. 2013. 7: 117-125.
- Singer O, Marr RA, Rockenstein E, Crews L, Coufal NG, Gage FH, Verma IM, Masliah E. Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nat Neurosci. 2005. 8: 1343-1349. https://doi.org/10.1038/nn1531
- Tan L, Yu JT, Tan MS, Liu QY, Wang HF, Zhang W, Jiang T, Tan L. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease. J Alzheimers Dis. 2014. 40: 1017-1027. https://doi.org/10.3233/JAD-132144
- Tricoli JV, Jacobson JW. MicroRNA: potential for cancer detection, diagnosis, and prognosis. Cancer Res. 2007. 67: 4553-4555. https://doi.org/10.1158/0008-5472.CAN-07-0563
- van Rooij E, Purcell AL, Levin AA. Developing microRNA therapeutics. Circ Res. 2012. 110: 496-507. https://doi.org/10.1161/CIRCRESAHA.111.247916
- Wang G, Zhang Y, Chen B, Cheng J. Preliminary studies on Alzheimer's disease using cDNA microarrays. Mech Ageing Dev. 2003. 124: 115-124. https://doi.org/10.1016/S0047-6374(02)00188-4
- Whalley LJ. Early-onset Alzheimer's disease in Scotland: environmental and familial factors. Brit J Psychiat. 2001. 178: s53-s59. https://doi.org/10.1192/bjp.178.40.s53
- Zilka N, Novak M. The tangled story of Alois Alzheimer. Bratisl Lek Listy. 2006. 107: 343-345.